SNY logo

SNY
Sanofi-Aventis

5,821
Mkt Cap
$114.26B
Volume
211,445.00
52W High
$60.12
52W Low
$44.62
PE Ratio
19.73
SNY Fundamentals
Price
$47.31
Prev Close
$47.22
Open
$47.75
50D MA
$47.60
Beta
0.29
Avg. Volume
3.71M
EPS (Annual)
$2.41
P/B
1.36
Rev/Employee
$643,658.13
$134,040.08
Loading...
Loading...
News
all
press releases
FDA Approves Sanofi And Regeneron's Dupixent As First Medicine For Allergic Fungal Rhinosinusitis
(RTTNews) - Sanofi (SNY, SAN.PA) said FDA has approved Dupixent or dupilumab for the treatment of adult and pediatric patients aged 6 years and older with allergic fungal rhinosinusitis who have a...
Nasdaq News: Markets·9h ago
News Placeholder
More News
News Placeholder
BMRN Beats on Q4 Earnings, to Withdraw Roctavian From Market
BioMarin beats Q4 earnings estimates as Voxzogo drives year-over-year revenue growth. The company decides to voluntarily withdraw its hemophilia gene therapy.
Zacks·22h ago
News Placeholder
IOVA vs. RIGL: Which Small-Cap Biotech Has More Upside Potential?
With Amtagvi sales surging but shares down 46%, can Iovance's growth runway outshine Rigel's strong 2025 rally?
Zacks·1d ago
News Placeholder
Kraig Biocraft Laboratories Featured on the Cover of National Geographic
Kraig Biocraft Laboratories (OTCQB: KBLB) groundbreaking work in commercializing spider silk is featured on the cover of the March 2026 issue of National Geographic magazine.
24-7 Market News·2d ago
News Placeholder
Sanofi $SNY Shares Purchased by NewEdge Wealth LLC
NewEdge Wealth LLC boosted its holdings in Sanofi (NASDAQ:SNY - Free Report) by 63.1% during the 3rd quarter, according to its most recent disclosure with the SEC. The firm owned 67,303 shares of the...
MarketBeat·4d ago
News Placeholder
Sanofi (NASDAQ:SNY) Cut to "Buy" at Wall Street Zen
Wall Street Zen downgraded Sanofi from a "strong-buy" rating to a "buy" rating in a research report on Saturday...
MarketBeat·4d ago
News Placeholder
Moderna Stock Jumps After FDA Reverses Course on Flu Shot
MRNA stock rises 6% as the FDA agrees to review its flu vaccine filing after a surprise reversal, with a decision expected by Aug. 5, 2026.
Zacks·6d ago
News Placeholder
Sanofi $SNY Shares Acquired by Aberdeen Group plc
Aberdeen Group plc increased its stake in shares of Sanofi (NASDAQ:SNY - Free Report) by 17.7% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission...
MarketBeat·6d ago
News Placeholder
It’s Not Synthetic, It’s Real. Kraig Labs Nears Spider Silk Breakthrough
Kraig Biocraft Laboratories (OTCQB:KBLB), the undisputed global leader in the development and commercialization of spider silk, is entering what may prove to be the defining phase of its multi-decade development arc, as the company accelerates toward commercial-scale production of biodegradable spider silk derived from transgenic silkworms
24-7 Market News·7d ago
News Placeholder
Will Tavalisse Continue to Drive Rigel Pharmaceuticals' Growth in 2026?
RIGL's 2025 sales jump 60% to $232M, led by Tavalisse. With 2026 product sales seen at $255-$265M, can its momentum withstand rising competition?
Zacks·7d ago
<
1
2
...
>

Latest SNY News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.